Design and Baseline Patient Characteristics of the Prospective, Observational, Multicenter and Multinational Cohort Study Comparing Radiofrequency with Cryoablation for Pulmonary Vein Isolation in Patients with Atrial Fibrillation—The Freeze Cohort Study

Ellen Hoffmann, Uwe Dorwarth, Karl Heinz Kuck, Jürgen Vogt, Malte Kuniss, Steffen Schneider, Jürgen Tebbenjohanns, Kyong Ryul Julian Chun, Dietrich Andresen, Stefan Spitzer, Thorsten Lewalter, Stephan Willems (+4 others)
2014 International journal of clinical medicine  
Aims: The FREEZE-cohort study (NCT 01360008) is a prospective observational, multicenter and multinational study to evaluate safety and effectiveness of cryoballoon ablation for pulmonary vein isolation as compared to radiofrequency ablation in patients with paroxysmal or persistent atrial fibrillation (lasting <one year) under the conditions of clinical routine. Methods and Results: The study started in 2011 and anticipates inclusion up to 2000 patients in each of the two treatment groups. A
more » ... tal of 37 centers from 8 countries worldwide, all experienced in at least one of the two ablation techniques, participate in the study. The primary outcome parameter of the study is defined as atrial fibrillation recurrence rate during twelve months of follow-up. Secondary outcome parameters include primary success rates, complication rates in general, specific complications with respect to phrenic nerve palsy and pulmonary vein stenosis, radiation exposure, clinical course including death and repeat ablation. Finally specific procedural aspects will be evaluated in a descriptive manner. Preliminary data of the first 1882 patients show that in clinical practice cryoablation is preferentially performed in patients with paroxysmal atrial fibrillation, whereas application of radiofrequency ablation is equally distributed between patients with persistent and paroxysmal atrial fibrillation. Conclusion: Based on multi-center and multi-national data the FREEZE-cohort study will provide important information on long-term efficacy, clinical effectiveness, complication rates and procedural differences between atrial fibrillation patients treated with either cryoablation or radiofrequency ablation. Publication Kojodjojo P. et al. 2010 [8] Vogt J. et al. 2013 [9] Packer D.L. et al. 2013 [10] Schmidt M. et al. 2013 [11]
doi:10.4236/ijcm.2014.519149 fatcat:43wgbpkbrfdgzcn4rqtv2ntziy